{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:32:41Z","timestamp":1790893961030,"version":"4.1.0"},"reference-count":130,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tumorigenesis is a complex multifactorial and multistep process in which tumors can utilize a diverse repertoire of immunosuppressive mechanisms to evade host immune attacks. The degradation of tryptophan into immunosuppressive kynurenine is considered an important immunosuppressive mechanism in the tumor microenvironment. There are three enzymes, namely, tryptophan 2,3-dioxygenase (TDO), indoleamine 2,3-dioxygenase 1 (IDO1), and indoleamine 2,3-dioxygenase 2 (IDO2), involved in the metabolism of tryptophan. IDO1 has a wider distribution and higher activity in catalyzing tryptophan than the other two; therefore, it has been studied most extensively. IDO1 is a cytosolic monomeric, heme-containing enzyme, which is now considered an authentic immune regulator and represents one of the promising drug targets for tumor immunotherapy. Collectively, this review highlights the regulation of IDO1 gene expression and the ambivalent mechanisms of IDO1 on the antitumoral immune response. Further, new therapeutic targets <jats:italic>via<\/jats:italic> the regulation of IDO1 are discussed. A comprehensive analysis of the expression and biological function of IDO1 can help us to understand the therapeutic strategies of the inhibitors targeting IDO1 in malignant tumors.<\/jats:p>","DOI":"10.3389\/fimmu.2021.800630","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T09:10:18Z","timestamp":1640250618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaotian","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14070606","article-title":"Kynurenines as a Novel Target for the Treatment of Malignancies","volume":"14","author":"Mor","year":"2021","journal-title":"Pharm (Basel Switzerland)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.707277","article-title":"Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jons.2017.04.001","article-title":"Indoleamine 2,3-Dioxygenase (IDO): Only an Enzyme or a Checkpoint Controller","volume":"32","author":"Bilir","year":"2017","journal-title":"J Oncological Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-Dioxygenase Is a Signaling Protein in Long-Term Tolerance by Dendritic Cells","volume":"129","author":"Pallotta","year":"2011","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000116","article-title":"New Insights From Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties Between Groups of IDO1 Structures","volume":"1510","author":"Mammoli","year":"2020","journal-title":"ChemMedChem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-6606-2-8","article-title":"Tryptophan 2,3-Dioxygenase Is a Key Modulator of Physiological Neurogenesis and Anxiety-Related Behavior in Mice","volume":"2","author":"Kanai","year":"2009","journal-title":"Mol Brain"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-016-9824-z","article-title":"TDO as a Therapeutic Target in Brain Diseases","volume":"314","author":"Yu","year":"2016","journal-title":"Metab Brain Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00034","article-title":"Tryptophan-Degrading Enzymes in Tumoral Immune Resistance","volume":"6","author":"van Baren","year":"2015","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01185","article-title":"Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies","volume":"11","author":"Zhai","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism","volume":"2815380","author":"Munn","year":"1998","journal-title":"Sci (New York NY)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508996103","article-title":"Crystal Structure of Human Indoleamine 2,3-Dioxygenase: Catalytic Mechanism of O2 Incorporation by a Heme-Containing Dioxygenase","volume":"1038","author":"Sugimoto","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41467-017-01725-8","article-title":"Structural Insights Into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","volume":"81","author":"Lewis-Ballester","year":"2017","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12954","article-title":"Distinct Roles of Immunoreceptor Tyrosine-Based Motifs in Immunosuppressive Indoleamine 2,3-Dioxygenase 1","volume":"211","author":"Albini","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949756","article-title":"Class IA PI3Ks Regulate Subcellular and Functional Dynamics of IDO1","volume":"2112","author":"Iacono","year":"2020","journal-title":"EMBO Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15446","article-title":"Enzymes, Pseudoenzymes, and Moonlighting Proteins: Diversity of Function in Protein Superfamilies","volume":"28719","author":"Jeffery","year":"2020","journal-title":"FEBS J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0137","article-title":"Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues","volume":"32","author":"Theate","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.08.002","article-title":"Advanced Age Negatively Impacts Survival in an Experimental Brain Tumor Model","volume":"630","author":"Ladomersky","year":"2016","journal-title":"Neurosci Lett"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm1196","article-title":"Inhibition of Indoleamine 2,3-Dioxygenase, an Immunoregulatory Target of the Cancer Suppression Gene Bin1, Potentiates Cancer Chemotherapy","volume":"113","author":"Muller","year":"2005","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.lungcan.2019.02.005","article-title":"High BIN1 Expression has a Favorable Prognosis in Malignant Pleural Mesothelioma and Is Associated With Tumor Infiltrating Lymphocytes","volume":"130","author":"Ahmadzada","year":"2019","journal-title":"Lung Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/2326-6066.Cir-16-0400","article-title":"Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance","volume":"58","author":"Hennequart","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.091173","article-title":"Towards a Genetic Definition of Cancer-Associated Inflammation: Role of the IDO Pathway","volume":"1765","author":"Prendergast","year":"2010","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO Expression in Human Cancer Is Sustained by an Autocrine Signaling Loop Involving IL-6, STAT3 and the AHR","volume":"54","author":"Litzenburger","year":"2014","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12022-018-9514-y","article-title":"PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma","volume":"291","author":"Rosenbaum","year":"2018","journal-title":"Endocr Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002754","article-title":"IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer","volume":"2696","author":"Kiyozumi","year":"2019","journal-title":"Ann Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03390-9","article-title":"Association of PD-L1 and IDO1 Expression With JAK-STAT Pathway Activation in Soft-Tissue Leiomyosarcoma","volume":"1475","author":"Iwasaki","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/jci21583","article-title":"Expression of Indoleamine 2,3-Dioxygenase by Plasmacytoid Dendritic Cells in Tumor-Draining Lymph Nodes","volume":"1142","author":"Munn","year":"2004","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193178","article-title":"Microenvironmental Cues Enhance Mesenchymal Stem Cell-Mediated Immunomodulation and Regulatory T-Cell Expansion","volume":"133","author":"Kadle","year":"2018","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13560","article-title":"High IDO-1 Expression in Tumor Endothelial Cells Is Associated With Response to Immunotherapy in Metastatic Renal Cell Carcinoma","volume":"1095","author":"Seeber","year":"2018","journal-title":"Cancer Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-017-0244-0","article-title":"Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers","volume":"242","author":"Cui","year":"2018","journal-title":"Pathol Oncol Res POR"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25393","article-title":"Peritumoral Endothelial Indoleamine 2, 3-Dioxygenase Expression Is an Early Independent Marker of Disease Relapse in Colorectal Cancer and Is Influenced by DNA Mismatch Repair Profile","volume":"938","author":"Meireson","year":"2018","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051265","article-title":"Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2019.01.012","article-title":"Multiple Myeloma Cell-Derived IL-32\u03b3 Increases the Immunosuppressive Function of Macrophages by Promoting Indoleamine 2,3-Dioxygenase (IDO) Expression","volume":"446","author":"Yan","year":"2019","journal-title":"Cancer Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040877","article-title":"Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma","volume":"12","author":"Karihtala","year":"2020","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7438","article-title":"Tumoral Indoleamine 2, 3-Dioxygenase 1 Is Regulated by Monocytes and T Lymphocytes Collaboration in Hepatocellular Carcinoma","volume":"712","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01051","article-title":"Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-\u03b3 and TNF-\u03b1 as Potential Biomarker of Prostate Cancer Progression","volume":"9","author":"Banzola","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2019.03.043","article-title":"Indoleamine 2,3-Dioxygenase Activation by Interferon Gamma in Vascular Endothelial Rat Cells Requires Noncanonical NF-\u03bab Signaling","volume":"516","author":"Liang","year":"2019","journal-title":"Transplant Proc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010089","article-title":"The Dark Side of IFN-\u03b3: Its Role in Promoting Cancer Immunoevasion","volume":"19","author":"Mojic","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.01.006","article-title":"Type I\/II Interferon Balance in the Regulation of Brain Physiology and Pathology","volume":"373","author":"Deczkowska","year":"2016","journal-title":"Trends Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-17-0120","article-title":"Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival","volume":"2321","author":"Zhai","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/107999000312531","article-title":"Analysis of Transcription Factors Regulating Induction of Indoleamine 2,3-Dioxygenase by IFN-Gamma","volume":"202","author":"Du","year":"2000","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1038\/oncsis.2016.7","article-title":"Hepatic Carcinoma-Associated Fibroblasts Induce IDO-Producing Regulatory Dendritic Cells Through IL-6-Mediated STAT3 Activation","volume":"5","author":"Cheng","year":"2016","journal-title":"Oncogenesis"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0810278105","article-title":"SOCS3 Drives Proteasomal Degradation of Indoleamine 2,3-Dioxygenase (IDO) and Antagonizes IDO-Dependent Tolerogenesis","volume":"10552","author":"Orabona","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine Wnt5a-Beta-Catenin Signaling Triggers a Metabolic Program That Drives Dendritic Cell Tolerization","volume":"481","author":"Zhao","year":"2018","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig Regulates Tryptophan Catabolism In Vivo","volume":"311","author":"Grohmann","year":"2002","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.01.005","article-title":"A Relay Pathway Between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells","volume":"462","author":"Mondanelli","year":"2017","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2020.101351","article-title":"Soluble CD83 Inhibits Acute Rejection by Up Regulating TGF-\u03b2 and IDO Secretion in Rat Liver Transplantation","volume":"64","author":"Xiong","year":"2021","journal-title":"Transplant Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-15-0420","article-title":"Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy","volume":"2124","author":"Zhai","year":"2015","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200108)31:8<2313::aid-immu2313>3.0.co;2-s","article-title":"Lipopolysaccharide Induction of Indoleamine 2,3-Dioxygenase Is Mediated Dominantly by an IFN-Gamma-Independent Mechanism","volume":"318","author":"Fujigaki","year":"2001","journal-title":"Eur J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e001372","DOI":"10.1136\/jitc-2020-001372","article-title":"Mitochondrial Lon-Induced mtDNA Leakage Contributes to PD-L1-Mediated Immunoescape via STING-IFN Signaling and Extracellular Vesicles","volume":"8","author":"Cheng","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nature13323","article-title":"Aryl Hydrocarbon Receptor Control of a Disease Tolerance Defence Pathway","volume":"5117508","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737184","article-title":"On Watching the Watchers: IDO and Type I\/II IFN","volume":"374","author":"Puccetti","year":"2007","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00618-6","article-title":"Exosome-Derived miR-142-5p Remodels Lymphatic Vessels and Induces IDO to Promote Immune Privilege in the Tumour Microenvironment","volume":"282","author":"Zhou","year":"2021","journal-title":"Cell Death Differ"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00619","article-title":"MicroRNA-153 Decreases Tryptophan Catabolism and Inhibits Angiogenesis in Bladder Cancer by Targeting Indoleamine 2,3-Dioxygenase 1","volume":"9","author":"Zhang","year":"2019","journal-title":"Front Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4137\/ijtr.s2129","article-title":"L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications","volume":"2","author":"Richard","year":"2009","journal-title":"Int J tryptophan Res IJTR"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010145","article-title":"The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition","volume":"12","author":"Moretti","year":"2020","journal-title":"Cancers"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4180","article-title":"Reversal of Indoleamine 2,3-Dioxygenase-Mediated Cancer Immune Suppression by Systemic Kynurenine Depletion With a Therapeutic Enzyme","volume":"368","author":"Triplett","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00158","article-title":"Tryptophan Metabolic Pathways and Brain Serotonergic Activity: A Comparative Review","volume":"10","author":"Hoglund","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jaci.2017.06.013","article-title":"Functional Role of Kynurenine and Aryl Hydrocarbon Receptor Axis in Chronic Rhinosinusitis With Nasal Polyps","volume":"1412","author":"Wang","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.Cir-19-0041","article-title":"Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors","volume":"81","author":"Schramme","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S252929","article-title":"TDO Promotes Hepatocellular Carcinoma Progression","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/2326-6066.Cir-19-0040","article-title":"Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers","volume":"81","author":"Hoffmann","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an Indoleamine 2,3-Dioxygenase-Like Protein Found in Humans and Mice","volume":"3961","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00839","article-title":"Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-Small Cell Lung Cancer: A Potential New Prognostic Tool","volume":"11","author":"Mandarano","year":"2020","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-018-2869-6","article-title":"Investigation of the Aryl Hydrocarbon Receptor and the Intrinsic Tumoral Component of the Kynurenine Pathway of Tryptophan Metabolism in Primary Brain Tumors","volume":"1392","author":"Guastella","year":"2018","journal-title":"J Neuro-Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.6.2277-2284.1994","article-title":"Antiparasitic and Antiproliferative Effects of Indoleamine 2,3-Dioxygenase Enzyme Expression in Human Fibroblasts","volume":"626","author":"Gupta","year":"1994","journal-title":"Infect Immun"},{"key":"B67","article-title":"IFN-Gamma-Mediated Antimicrobial Response. Indoleamine 2,3-Dioxygenase-Deficient Mutant Host Cells No Longer Inhibit Intracellular Chlamydia Spp. Or Toxoplasma Growth","volume":"15012","author":"Thomas","year":"1993","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00384","article-title":"New Insights Into IDO Biology in Bacterial and Viral Infections","volume":"5","author":"Schmidt","year":"2014","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2021.09.018","article-title":"IDO Activity Forecasts Obesity in Males and Premenopausal Females in a 10-Year Follow-Up Study:The Cardiovascular Risk in Young Finns Study","volume":"336","author":"Niinisalo","year":"2021","journal-title":"Atherosclerosis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.671025","article-title":"Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation","volume":"12","author":"Lassiter","year":"2021","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.702048","article-title":"ZikaInhibition of Tryptophan Catabolism Is Associated With Neuroprotection During Virus Infection","volume":"12","author":"Marim","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2021.103361","article-title":"Tryptophan Metabolism and Immune Regulation in the Human Placenta","volume":"147","author":"Silvano","year":"2021","journal-title":"J Reprod Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-12-0014","article-title":"IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development","volume":"28","author":"Smith","year":"2012","journal-title":"Cancer Discov"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1038\/s41467-019-12361-9","article-title":"Metabolomic Adaptations and Correlates of Survival to Immune Checkpoint Blockade","volume":"101","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism","volume":"1899","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase","volume":"225","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1500845","article-title":"The PTEN Pathway in Tregs Is a Critical Driver of the Suppressive Tumor Microenvironment","volume":"110","author":"Sharma","year":"2015","journal-title":"Sci Adv"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1240858","article-title":"The Stress Kinase GCN2 Does Not Mediate Suppression of Antitumor T Cell Responses by Tryptophan Catabolism in Experimental Melanomas","volume":"512","author":"Sonner","year":"2016","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.079","article-title":"Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing","volume":"179","author":"Van de Velde","year":"2016","journal-title":"Cell Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21716","article-title":"IDO Inhibits a Tryptophan Sufficiency Signal That Stimulates mTOR: A Novel IDO Effector Pathway Targeted by D-1-Methyl-Tryptophan","volume":"19","author":"Metz","year":"2012","journal-title":"Oncoimmunology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.05.018","article-title":"Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR Restricts a Treg-Macrophage Suppressive Axis Induced by L-Kynurenine","volume":"111","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3109\/14653240903271230","article-title":"Indoleamine-2,3-Dioxygenase Enzyme Expression and Activity in Polarized Dendritic Cells","volume":"118","author":"Wolf","year":"2009","journal-title":"Cytotherapy"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-11-191197","article-title":"Indoleamine 2,3-Dioxygenase-Expressing Mature Human Monocyte-Derived Dendritic Cells Expand Potent Autologous Regulatory T Cells","volume":"1143","author":"Chung","year":"2009","journal-title":"Blood"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.8.5396","article-title":"The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation","volume":"1818","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.02.024","article-title":"Targeting Myeloid-Derived Suppressor Cells With Colony Stimulating Factor-1 Receptor Blockade Can Reverse Immune Resistance to Immunotherapy in Indoleamine 2,3-Dioxygenase-Expressing Tumors","volume":"6","author":"Holmgaard","year":"2016","journal-title":"EBioMedicine"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses Through IDO Expression and Correlate With Lymph Node Metastasis in Patients With Breast Cancer","volume":"1907","author":"Yu","year":"2013","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/15384047.2018.1450116","article-title":"Tumor-Infiltrating Treg, MDSC, and IDO Expression Associated With Outcomes of Neoadjuvant Chemotherapy of Breast Cancer","volume":"198","author":"Li","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner","volume":"132","author":"Holmgaard","year":"2015","journal-title":"Cell Rep"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060842","article-title":"Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways","volume":"8","author":"Park","year":"2019","journal-title":"J Clin Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00274","article-title":"IDO Targeting in Sarcoma: Biological and Clinical Implications","volume":"11","author":"Nafia","year":"2020","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0226","article-title":"IDO1 Signaling Through GCN2 in a Subpopulation of Gr-1(+) Cells Shifts the IFNgamma\/IL6 Balance to Promote Neovascularization","volume":"95","author":"Dey","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.3975","article-title":"Gene Silencing of Indoleamine 2,3-Dioxygenase Hinders Tumor Growth Through Angiogenesis Inhibition","volume":"506","author":"Pan","year":"2017","journal-title":"Int J Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28959","article-title":"Biological and Anti-Vascular Activity Evaluation of Ethoxy-Erianin Phosphate as a Vascular Disrupting Agent","volume":"120","author":"Yuan","year":"2019","journal-title":"J Cell Biochem"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.18781","article-title":"Association of Breast Carcinoma Growth With a Non-Canonical Axis of Ifn\u03b3\/Ido1\/Tsp1","volume":"849","author":"Lopes-Bastos","year":"2017","journal-title":"Oncotarget"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular Carcinoma-Associated Fibroblasts Trigger NK Cell Dysfunction via PGE2 and IDO","volume":"3182","author":"Li","year":"2012","journal-title":"Cancer Lett"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2017.01.022","article-title":"Non-Tumor Cell IDO1 Predominantly Contributes to Enzyme Activity and Response to CTLA-4\/PD-L1 Inhibition in Mouse Glioblastoma","volume":"62","author":"Zhai","year":"2017","journal-title":"Brain Behav Immun"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3624","article-title":"IDO Decreases Glycolysis and Glutaminolysis by Activating GCN2K, While It Increases Fatty Acid Oxidation by Activating AhR, Thus Preserving CD4+ T\u2212cell Survival and Proliferation","volume":"421","author":"Eleftheriadis","year":"2018","journal-title":"Int J Mol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma","volume":"3317","author":"Schadendorf","year":"2015","journal-title":"J Clin Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"1684","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01809","article-title":"In Vivo Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to Pharmacodynamic Activity","volume":"636","author":"Serafini","year":"2020","journal-title":"J Med Chem"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities","volume":"393","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxw014","article-title":"Mechanisms of Tumor Escape in the Context of the T-Cell-Inflamed and the Non-T-Cell-Inflamed Tumor Microenvironment","volume":"288","author":"Spranger","year":"2016","journal-title":"Int Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2190-4","article-title":"Indoleamine 2,3-Dioxygenase Provides Adaptive Resistance to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma","volume":"678","author":"Brown","year":"2018","journal-title":"Cancer Immunol Immunother CII"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96329","article-title":"STAT3\/p53 Pathway Activation Disrupts IFN-Beta-Induced Dormancy in Tumor-Repopulating Cells","volume":"1283","author":"Liu","year":"2018","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e002057","DOI":"10.1136\/jitc-2020-002057","article-title":"Phase II Trial of the IDO Pathway Inhibitor Indoximod Plus Pembrolizumab for the Treatment of Patients With Advanced Melanoma","volume":"9","author":"Zakharia","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30274-8","article-title":"Epacadostat Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Patients With Unresectable or Metastatic Melanoma (ECHO-301\/KEYNOTE-252): A Phase 3, Randomised, Double-Blind Study","volume":"208","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-1392","article-title":"Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma","volume":"27","author":"Zhai","year":"2021","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-17-3573","article-title":"IDO1 Inhibition Synergizes With Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma","volume":"2411","author":"Ladomersky","year":"2018","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121018","article-title":"Indoleamine 2,3-Dioxygenase (Ido) Inhibitors and Their Nanomedicines for Cancer Immunotherapy","volume":"276","author":"Guo","year":"2021","journal-title":"Biomaterials"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061547","article-title":"Reciprocal Regulation Between Indoleamine 2,3-Dioxigenase 1 and Notch1 Involved in Radiation Response of Cervical Cancer Stem Cells","volume":"12","author":"Low","year":"2020","journal-title":"Cancers"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00968","article-title":"Tumor-Targeted Gene Silencing IDO Synergizes PTT-Induced Apoptosis and Enhances Anti-Tumor Immunity","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113873109","article-title":"Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase","volume":"1097","author":"Pilotte","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B114","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-019-0103-4","article-title":"Both IDO1 and TDO Contribute to the Malignancy of Gliomas via the Kyn-AhR-AQP4 Signaling Pathway","volume":"51","author":"Du","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0404-8","article-title":"The Landscape of Cancer Cell Line Metabolism","volume":"255","author":"Li","year":"2019","journal-title":"Nat Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.12.031","article-title":"Levo-1-Methyl Tryptophan Aggravates the Effects of Mouse Hepatitis Virus (MHV-A59) Infection","volume":"242","author":"Duhalde Vega","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.imlet.2019.11.004","article-title":"The Autoimmune Response Elicited by Mouse Hepatitis Virus (MHV-A59) Infection Is Modulated by Liver Tryptophan-2,3-Dioxygenase (TDO)","volume":"217","author":"Duhalde Vega","year":"2020","journal-title":"Immunol Lett"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO Pathways to Treat Cancer: Lessons From the ECHO-301 Trial and Beyond","volume":"411","author":"Muller","year":"2019","journal-title":"Semin immunopathol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The Therapeutic Potential of Targeting Tryptophan Catabolism in Cancer","volume":"1221","author":"Opitz","year":"2020","journal-title":"Br J Cancer"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081899","article-title":"IDO1-Targeted Therapy Does Not Control Disease Development in the Emicro-TCL1 Mouse Model of Chronic Lymphocytic Leukemia","volume":"13","author":"Ozturk","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-019-0089-7","article-title":"Salmonella-Mediated Therapy Targeting Indoleamine 2, 3-Dioxygenase 1 (IDO) Activates Innate Immunity and Mitigates Colorectal Cancer Growth","author":"Phan","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"B122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00262-019-02438-1","article-title":"A Highly Efficient Modality to Block the Degradation of Tryptophan for Cancer Immunotherapy: Locked Nucleic Acid-Modified Antisense Oligonucleotides to Inhibit Human Indoleamine 2,3-Dioxygenase 1\/Tryptophan 2,3-Dioxygenase Expression","volume":"691","author":"Klar","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"B123","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","article-title":"Tryptophan and Indole Metabolism in Immune Regulation","volume":"70","author":"Fiore","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01244","article-title":"The Prognostic Value of Indoleamine-2,3-Dioxygenase Gene Expression in Urine of Prostate Cancer Patients Undergoing Radical Prostatectomy as First Treatment of Choice","volume":"11","author":"Th\u00fcring","year":"2020","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01243","article-title":"Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1","volume":"11","author":"Botticelli","year":"2020","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1159\/000492849","article-title":"The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence From a Systematic Review and Meta-Analysis","volume":"491","author":"Yu","year":"2018","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1158\/1078-0432.Ccr-07-0942","article-title":"Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates With Long-Term Survival of Patients With Renal Cell Carcinoma","volume":"1323","author":"Riesenberg","year":"2007","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2003.03259.x","article-title":"Immunoactivative Role of Indoleamine 2,3-Dioxygenase in Human Hepatocellular Carcinoma","volume":"193","author":"Ishio","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-14-2275","article-title":"Prognostic Significance of Tryptophan Catabolism in Adult T-Cell Leukemia\/Lymphoma","volume":"2112","author":"Masaki","year":"2015","journal-title":"Clin Cancer Res an Off J Am Assoc Cancer Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.06.018","article-title":"The Kynurenine to Tryptophan Ratio as a Prognostic Tool for Glioblastoma Patients Enrolling in Immunotherapy","volume":"2212","author":"Zhai","year":"2015","journal-title":"J Clin Neurosci Off J Neurosurgical Soc Australasia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.800630\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T09:10:22Z","timestamp":1640250622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.800630\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":130,"alternative-id":["10.3389\/fimmu.2021.800630"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.800630","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"article-number":"800630"}}